• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直接压片法制备氯氮平口腔崩解片的处方设计与评价

Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.

作者信息

Olmez S S, Vural I, Sahin S, Ertugrul A, Capan Y

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.

出版信息

Pharmazie. 2013 Feb;68(2):110-6.

PMID:23469682
Abstract

In this study, clozapine orally disintegrating tablets (ODTs) were prepared by direct compression method. Disintegration time, resistance to crushing of tablets, porosity, friability, dissolution tests were performed and dissolution profiles of ODTs were investigated. Morphological and interaction studies were also performed. Friability values were found to be less than 1%. All tablet formulations disintegrated within 1 min and fulfilled the 3 min disintegration time required for ODTs given in the European Pharmacopoeia. More than 85% of the labeled amount of clozapine was dissolved in 15 min from the ODTs. No interaction or changes were found between active substance and excipients. As a result of the studies, ODT formulations developed in this study can be suggested as promising formulations, which assist development and manufacturing a generic product of clozapine.

摘要

在本研究中,采用直接压片法制备了氯氮平口腔崩解片(ODT)。进行了崩解时间、片剂抗压强度、孔隙率、脆碎度、溶出度测试,并研究了ODT的溶出曲线。还进行了形态学和相互作用研究。发现脆碎度值小于1%。所有片剂配方在1分钟内崩解,符合欧洲药典中ODT规定的3分钟崩解时间要求。从ODT中,超过85%标示量的氯氮平在15分钟内溶解。在活性物质和辅料之间未发现相互作用或变化。研究结果表明,本研究开发的ODT制剂可被认为是有前景的制剂,有助于氯氮平仿制药的开发和生产。

相似文献

1
Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.直接压片法制备氯氮平口腔崩解片的处方设计与评价
Pharmazie. 2013 Feb;68(2):110-6.
2
Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes.氯氮平/羟丙基-β-环糊精包合物口腔崩解片的处方前研究与体内评价。
AAPS PharmSciTech. 2013 Jun;14(2):854-60. doi: 10.1208/s12249-013-9973-x. Epub 2013 May 7.
3
Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.冷冻干燥法制备纳米晶体吡罗昔康口崩片的制剂策略与评价。
Int J Pharm. 2014 Jun 5;467(1-2):27-33. doi: 10.1016/j.ijpharm.2014.03.047. Epub 2014 Mar 26.
4
Fast and pH-dependent release of domperidone from orally disintegrating tablets.口服速崩片的快速且 pH 依赖性的多潘立酮释放。
Pharm Dev Technol. 2013 Jul-Aug;18(4):897-905. doi: 10.3109/10837450.2011.583925. Epub 2012 Feb 3.
5
IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.在格列齐特速释片中鹰嘴豆(Cicer arietinum)淀粉作为药用辅料的特性鉴定
Acta Pol Pharm. 2016 Mar-Apr;73(2):469-78.
6
Further improvement of orally disintegrating tablets using micronized ethylcellulose.进一步使用微粉化乙基纤维素改善口崩片。
Int J Pharm. 2012 Feb 28;423(2):351-9. doi: 10.1016/j.ijpharm.2011.10.050. Epub 2011 Nov 26.
7
Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.制备布洛芬颗粒热熔挤出的口腔崩解片(ODTs)的开发和评价。
Colloids Surf B Biointerfaces. 2011 Sep 1;86(2):275-84. doi: 10.1016/j.colsurfb.2011.04.007. Epub 2011 Apr 13.
8
PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES.采用共处理混合物制备的口腔崩解氯雷他定片的制备及表征
Acta Pol Pharm. 2016 Mar-Apr;73(2):453-60.
9
Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.西洛他唑-β-环糊精包合物口腔崩解片的研制与评价
Drug Dev Ind Pharm. 2015;41(10):1589-607. doi: 10.3109/03639045.2014.972413. Epub 2014 Oct 28.
10
A new formulation for orally disintegrating tablets using a suspension spray-coating method.采用混悬液喷雾包衣法的新型口腔崩解片配方。
Int J Pharm. 2009 Dec 1;382(1-2):80-7. doi: 10.1016/j.ijpharm.2009.08.010. Epub 2009 Aug 15.